1. Home
  2. SCWX vs ANNX Comparison

SCWX vs ANNX Comparison

Compare SCWX & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCWX
  • ANNX
  • Stock Information
  • Founded
  • SCWX 1999
  • ANNX 2011
  • Country
  • SCWX United States
  • ANNX United States
  • Employees
  • SCWX N/A
  • ANNX N/A
  • Industry
  • SCWX Computer Software: Prepackaged Software
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCWX Technology
  • ANNX Health Care
  • Exchange
  • SCWX Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • SCWX 744.0M
  • ANNX 668.8M
  • IPO Year
  • SCWX 2016
  • ANNX 2020
  • Fundamental
  • Price
  • SCWX $8.36
  • ANNX $5.17
  • Analyst Decision
  • SCWX Sell
  • ANNX Strong Buy
  • Analyst Count
  • SCWX 2
  • ANNX 7
  • Target Price
  • SCWX $7.00
  • ANNX $15.80
  • AVG Volume (30 Days)
  • SCWX 273.7K
  • ANNX 1.4M
  • Earning Date
  • SCWX 12-04-2024
  • ANNX 11-14-2024
  • Dividend Yield
  • SCWX N/A
  • ANNX N/A
  • EPS Growth
  • SCWX N/A
  • ANNX N/A
  • EPS
  • SCWX N/A
  • ANNX N/A
  • Revenue
  • SCWX $346,352,000.00
  • ANNX N/A
  • Revenue This Year
  • SCWX N/A
  • ANNX N/A
  • Revenue Next Year
  • SCWX $4.26
  • ANNX N/A
  • P/E Ratio
  • SCWX N/A
  • ANNX N/A
  • Revenue Growth
  • SCWX N/A
  • ANNX N/A
  • 52 Week Low
  • SCWX $5.61
  • ANNX $2.27
  • 52 Week High
  • SCWX $9.76
  • ANNX $8.40
  • Technical
  • Relative Strength Index (RSI)
  • SCWX 54.35
  • ANNX 20.68
  • Support Level
  • SCWX $8.35
  • ANNX $5.05
  • Resistance Level
  • SCWX $8.39
  • ANNX $7.63
  • Average True Range (ATR)
  • SCWX 0.02
  • ANNX 0.39
  • MACD
  • SCWX -0.02
  • ANNX -0.25
  • Stochastic Oscillator
  • SCWX 20.00
  • ANNX 4.84

About SCWX SecureWorks Corp.

SecureWorks Corp is a cybersecurity provider of technology-driven solutions singularly focused on protecting its customers by outpacing and outmaneuvering the adversary. The company offers its customers the following services; software-as-a-service, or SaaS, solutions, managed solutions, and professional services, including incident response and adversarial services. Its solutions enable organizations to fortify their cyber defenses to prevent security breaches, detect malicious activity in real-time, prioritize and respond to security incidents, and predict emerging threats. The company's products consist of MDR, XDR, Threat Hunting, Log Management, NGAV, EDR, IDPS.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: